Researchers at Johns Hopkins University developed an experimental approach to protect insulin-producing cells in type 1 diabetes. The method aims to shield these cells from inflammatory damage, allowing them to survive longer. While the study was conducted in animal models, the results offer promising prospects for future human therapies. This aligns with ongoing efforts to find disease-modifying treatments that can slow or halt the progression of type 1 diabetes, rather than just managing symptoms.
About the Author
